Nathaniel Brinn

Part of Applied DNA Sciences, Inc., Spindle Biotech, Inc. is a Canadian company that has developed a proprietary RNA polymerase for large-scale mRNA vaccine production. The company focuses on producing high-quality RNA with significant reductions in dsRNA impurities, which reduces the cost of goods for production. The company, founded in 2017, is based in Toronto, Canada. Spindle Biotech was acquired by Applied DNA Sciences, Inc. on July 13, 2023, for $2.16 million. Spindle Biotech is also involved in collaborative research with Applied DNA to pursue a simplified and efficient method for mRNA production. The company was founded by Aaron Chung, who has been the CEO since incorporation.

Part of Applied DNA Sciences, Inc., Spindle Biotech, Inc. is a Canadian company that has developed a proprietary RNA polymerase for large-scale mRNA vaccine production. The company focuses on producing high-quality RNA with significant reductions in dsRNA impurities, which reduces the cost of goods for production. The company, founded in 2017, is based in Toronto, Canada. Spindle Biotech was acquired by Applied DNA Sciences, Inc. on July 13, 2023, for $2.16 million. Spindle Biotech is also involved in collaborative research with Applied DNA to pursue a simplified and efficient method for mRNA production. The company was founded by Aaron Chung, who has been the CEO since incorporation.

Part of Applied DNA Sciences, Inc., Spindle Biotech, Inc. is a Canadian company that has developed a proprietary RNA polymerase for large-scale mRNA vaccine production. The company focuses on producing high-quality RNA with significant reductions in dsRNA impurities, which reduces the cost of goods for production. The company, founded in 2017, is based in Toronto, Canada. Spindle Biotech was acquired by Applied DNA Sciences, Inc. on July 13, 2023, for $2.16 million. Spindle Biotech is also involved in collaborative research with Applied DNA to pursue a simplified and efficient method for mRNA production. The company was founded by Aaron Chung, who has been the CEO since incorporation.

Part of Applied DNA Sciences, Inc., Spindle Biotech, Inc. is a Canadian company that has developed a proprietary RNA polymerase for large-scale mRNA vaccine production. The company focuses on producing high-quality RNA with significant reductions in dsRNA impurities, which reduces the cost of goods for production. The company, founded in 2017, is based in Toronto, Canada. Spindle Biotech was acquired by Applied DNA Sciences, Inc. on July 13, 2023, for $2.16 million. Spindle Biotech is also involved in collaborative research with Applied DNA to pursue a simplified and efficient method for mRNA production. The company was founded by Aaron Chung, who has been the CEO since incorporation.